BerGenBio's Series B Round

BerGenBio raised a round of funding on June 27, 2013.

BerGenBio is an oncology-based biopharmaceutical company focused on pursuing therapeutic treatments for cancer and supporting the screening and identification of a wide array of potential targets in c…

Articles about BerGenBio's Series B Round: